Alfa Wassermann SpA

The health care industry has witnessed many changes in the past 35 years or so since I began reporting on it, yet in some ways very little seems to have changed. While there has been enormous progress

Theravance Biopharma Inc. believes its highly selective 5HT-4 receptor agonist, velusetrag (TD-5108), has potential as a new treatment for gastroparesis – or delayed stomach emptying – on the back o

No matter where you looked, pharmaceutical sales in dollar terms were down nearly 3% from 2014 to 2015; across the 350 drug-selling companies within the Scrip 100, sales fell 2.7% from $738bn in 2014

Japan has postponed the price listing and inclusion in the national health insurance reimbursement tariff of Merck Sharp & Dohme Ltd. 's Keytruda (pembrolizumab), putting back for the time being